Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RESOLUTION: A Double-blind, Randomized, Placebo-controlled, Phase II/III Study of the Efficacy and Safety of LAU-7b in the Treatment of Adult Hospitalized Patients With COVID-19 Disease

NCT04417257 is registered in ClinicalTrials.gov with Laurent Pharmaceuticals Inc. as lead sponsor.

NCT NCT04417257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04417257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RESOLUTION: A Double-blind, Randomized, Placebo-controlled, Phase II/III Study of the Efficacy and Safety of LAU-7b in the Treatment of Adult Hospitalized Patients With COVID-19 Disease
Lead sponsor
Laurent Pharmaceuticals Inc.
Phase
Phase 2/3
Overall status
Terminated
Start date
August 18, 2020
Completion date
May 30, 2024
Enrollment
351 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 disease